# LiveWire Ergogenics, Inc. (LVVV)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/LVVV/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 8.0K | $ -4.90M | $ 11.7K | $ 3.05M | $ -1.51M |
| 2024 | $ 319.7K | $ 82.7K | $ 145.7K | $ 3.35M | $ 3.24M |
| 2023 | $ 1.77M | $ 996.5K | $ 737.8K | $ 3.34M | $ 3.11M |
| 2022 | $ 2.16M | $ 764.2K | $ 442.8K | $ 3.20M | $ 2.03M |
| 2021 | $ 1.01M | $ -4.08M | $ -555.4K | $ 2.85M | $ 912.1K |
| 2020 | $ 739.3K | $ -2.04M | $ 77.7K | N/A | N/A |
| 2019 | $ 1.75M | $ -2.29M | $ -209.9K | $ 2.43M | $ 374.0K |
| 2018 | $ 96.4K | $ -5.23M | $ 251.9K | $ 1.37M | $ 36.7K |
| 2017 | $ 27.5K | $ -290.0K | N/A | N/A | N/A |
| 2015 | $ 63.4K | $ -688.5K | $ -286.0K | $ 534.4K | $ -911.6K |
| 2014 | $ 337.6K | $ -5.91M | $ -1.08M | $ 480.5K | $ -683.9K |
| 2013 | $ 207.9K | $ -1.80M | $ -711.4K | $ 488.0K | $ -765.5K |
| 2012 | $ 213.7K | $ -2.46M | $ -795.9K | $ 169.0K | $ -891.0K |
| 2011 | $ 591.1K | $ -109.5K | $ -347.8K | $ 67.4K | $ -782.8K |
| 2010 | $ 6.3K | $ -183.2K | $ -39.7K | $ 0 | $ -140.8K |
| 2009 | $ 0 | $ -49.5K | $ -42.8K | $ 0 | $ -19.4K |
| 2008 | $ -132.2K | $ -231.0K | $ -161.8K | $ 0 | $ -62.8K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -2.02 |
| Liabilities / Eq | -2.50 |
| Current Ratio | 0.06 |

## Other views

- [Metrics](https://sponda.capital/en/LVVV.md)
- [Charts](https://sponda.capital/en/LVVV/charts.md)
- [Compare](https://sponda.capital/en/LVVV/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.